Adaptive Therapy Sequence for Tachycardia Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current electrotherapy devices for treating tachycardiac arrhythmias, such as implantable cardioverters/defibrillators, are limited in their ability to adapt therapy sequences effectively, often relying solely on increasing shock energy or repeating previously successful therapies, which may not optimize treatment efficiency for different types of tachycardias.
Innovation Solution
An anti-tachycardia heart stimulator with a programmable therapy sequence that uses therapy success statistics to automatically adapt the order and intensity of electrical stimulation pulses and defibrillation shocks, optimizing treatment based on past success rates for specific types of tachycardias, including separate counters for stable and unstable rhythms and different heart rate zones.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If therapy sequences are adapted by increasing shock energy to treat tachycardia, then treatment effectiveness is improved, but patient discomfort and energy consumption increase
Solution Approach 1:
The therapy sequence dynamically adapts its structure based on real-time detection of tachycardia characteristics (heart rate, stability, zone classification). The control unit automatically reorders therapies within the sequence according to detected parameters, allowing the same therapy sequence to be optimized for different tachycardia types without increasing energy delivery.
Solution Approach 2:
The system changes the parameters of therapy delivery by reordering therapies based on tachycardia zone (slow/fast VT, stable/unstable rhythm). Instead of changing energy parameters, the system optimizes treatment effectiveness by altering the sequence parameters - delivering appropriate therapies at appropriate times based on detected arrhythmia characteristics.
2Device complexity
If a fixed therapy sequence is used for all tachycardia types, then device complexity is reduced, but treatment adaptability decreases
Solution Approach 1:
The system performs preliminary classification of tachycardia type (stable/unstable, slow/fast VT zones) before delivering therapy. Based on this preliminary detection, the control unit pre-arranges the optimal therapy sequence order, ensuring the most appropriate therapy is delivered first without requiring complex real-time reconfiguration during treatment.
Solution Approach 2:
While maintaining a fixed overall therapy sequence structure in memory, the system dynamically reorders therapies within that sequence based on detected tachycardia characteristics. This allows adaptability to different arrhythmia types while preserving the simplicity of a predefined sequence framework.
3Reliability
If high-energy defibrillation shocks are delivered immediately to ensure termination of tachycardia, then reliability of treatment is improved, but energy consumption and patient trauma increase
Solution Approach 1:
Instead of immediately delivering full-energy defibrillation shocks, the system applies partial action by first attempting lower-energy anti-tachycardia pacing (ATP) therapies. The therapy sequence is reordered to deliver progressively more intensive therapies only if less intensive ones fail, minimizing energy consumption while maintaining termination effectiveness.
Solution Approach 2:
The system uses feedback from tachycardia detection (heart rate, rhythm stability, zone classification) to determine the optimal starting point in the therapy sequence. This feedback mechanism ensures that the most appropriate therapy intensity is selected based on actual arrhythmia characteristics, avoiding unnecessary high-energy shocks.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances treatment efficiency by prioritizing therapy sequences with higher success rates, potentially reducing the need for higher-energy shocks and improving patient outcomes by tailoring therapy to the specific type and stability of tachycardia.
Implementation Method 1
stimulation pulses are delivered which have an overdrive stimulation rate that is elevated as compared with the intrinsic (tachycardiac) heart rate. This is intended to interrupt a reentry cycle of excitation of the myocardium
Implementation Method 2
defibrillation shocks, where the former usually have a lower energy than the latter. Defibrillation shocks are supposed to make the entire myocardium of an affected heart chamber refractory at the same time, and thus temporarily unresponsive to excitation, in order to thereby interrupt a circulating excitation of the heart muscle in question
Data Source
AI summary
An electrotherapy system, particularly an implantable heart stimulator, is configured as an electronic implant for electrical anti-tachycardia therapy of the heart, and includes at least one programmable therapy sequence (i.e. a sequence of several therapies that are delivered, one after the other, to treat a VT/VF episode). The implant has a therapy success memory for storing therapy success statistics for each therapy, as well as a therapy control unit that is configured to automatically undertake adaptation of the order of the therapies within a therapy sequence as a function of currently stored therapy success statistics.